Creative Medical Technology Holdings CELZ Institutional Ownership

NASDAQ CELZ

$0.94 +0.01 (+0.76%)

At close: Oct 1, 2026 · 4:00 PM EDT

Institutions by Trading Activity

13 Institutions

Increased 9 69.2%

Unchanged 2 15.4%

Reduced 2 15.4%

Ownership Statistics

13F · as of 30 Jun, 2026

Institutional Ownership

26.76%

▲+19.81 pp QoQ

Shares Held by Institutions

372.59K

of 1.39Mn outstanding

▲+359.72% QoQ

Shares Outstanding

1.39Mn

1.02Mn held outside 13F filers

Institutional Investors

filed 13F for Jun 2026

▲+2 vs prior quarter

Net Shares Added (QoQ)

+291.54K

accumulated since last quarter

Value of Holdings

$346.51K

reported market value

Shares Owned by Institutions

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Institutions

Accumulated Distributed

Latest quarter —

Net over range —

Accumulating quarters —

Ownership Summary

Quarter ending 30 Jun, 2026

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) has 13 institutional investors with active 13F positions as of June 2026.

Collectively, these holders controlled 26.8% of Creative Medical Technology Holdings's outstanding shares in June 2026, up from 7.0% in March 2026.
They increased total shares held in CELZ by 359.72% quarter over quarter, and investors in Creative Medical Technology Holdings increased 18.18% from a year ago.
During the quarter, 9 of these 13 funds increased positions in CELZ, 2 reduced exposure, and 2 held steady.
In total, institutional investors held 372.59K shares in Creative Medical Technology Holdings as of June 2026, up by 291.54K shares quarter on quarter, and up 313.8K shares year over year.
Hudson Bay Capital Management LP leads ownership in CELZ with 135.17K shares as of June 30, 2026, equal to 9.71% of outstanding shares.
Leading buyers of Creative Medical Technology Holdings shares for the quarter ending June 2026 were Hudson Bay Capital Management LP (135.17K), Anson Funds Management LP (105.55K), ARMISTICE CAPITAL, LLC (42.0K), XTX Topco Ltd (12.3K), Global Retirement Partners, LLC (4.12K).
Leading sellers of Creative Medical Technology Holdings shares for the quarter ending June 2026 were GEODE CAPITAL MANAGEMENT, LLC (12.49K), Morgan Stanley (20).
Per Business Quant data, the top 10 holders of Creative Medical Technology Holdings for the quarter ending June 2026 are Hudson Bay Capital Management LP (135.17K), Anson Funds Management LP (105.55K), ARMISTICE CAPITAL, LLC (42.0K), XTX Topco Ltd (26.56K), GEODE CAPITAL MANAGEMENT, LLC (25.8K), VANGUARD CAPITAL MANAGEMENT LLC (20.35K), VANGUARD FIDUCIARY TRUST CO (5.52K), Tower Research Capital LLC (TRC) (4.85K), Global Retirement Partners, LLC (4.12K), UBS Group AG (2.06K).

Form 13F Holdings

13 Institutional Holders

Report period 30 Jun, 2026

Total shares held 372.59K

Of outstanding 26.76%

#	Institution	CIK	Shares Held	% of Outstanding	Change (QoQ)	Change (%)	Value (USD)
1	Hudson Bay Capital Management LP	0001393825	135,170	9.71%	▲135,170	0.00%	$196.00K
2	Anson Funds Management LP	0001491072	105,549	7.58%	▲105,549	0.00%	$153.05K
3	ARMISTICE CAPITAL, LLC	0001601086	42,000	3.02%	▲42,000	0.00%	$60.90K
4	XTX Topco Ltd	0001828301	26,559	1.91%	▲12,299	+86.25%	$38.51K
5	GEODE CAPITAL MANAGEMENT, LLC	0001214717	25,799	1.85%	▼12,491	-32.62%	$37.42K
6	VANGUARD CAPITAL MANAGEMENT LLC	0002100119	20,350	1.46%	0	0.00%	$29.51K
7	VANGUARD FIDUCIARY TRUST CO	0000933478	5,518	0.40%	0	0.00%	$8.00K
8	Tower Research Capital LLC (TRC)	0001533421	4,853	0.35%	▲2,761	+131.98%	$7.04K
9	Global Retirement Partners, LLC	0001749744	4,118	0.30%	▲4,118	0.00%	$5.97K
10	UBS Group AG	0001610520	2,061	0.15%	▲2,060	+206,000.00%	$2.99K
11	Morgan Stanley	0000895421	514	0.04%	▼20	-3.75%	$745
12	Barclays Plc	0000312069	54	0.00%	▲54	0.00%	$78
13	SBI Securities Co., Ltd.	0001851815	43	0.00%	▲42	+4,200.00%	$62